Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris

被引:31
作者
Maurer, P. [1 ]
Sandulescu, T. [1 ]
Kriwalsky, M. S. [1 ]
Rashad, A. [1 ]
Hollstein, S. [1 ]
Stricker, I. [2 ]
Hoelzle, F. [3 ]
Kunkel, M. [1 ]
机构
[1] Ruhr Univ Bochum, Dept Oral & Plast Maxillofacial Surg, Bochum, Germany
[2] Ruhr Univ Bochum, Dept Pathol, Bochum, Germany
[3] Tech Univ Munich, Dept Oral & Plast Maxillofacial Surg, Munich, Germany
关键词
bisphosphonate; bisphosphonate-related osteonecrosis of the jaw; sinusitis maxillaris; cancer treatment; osteoporosis; RISK-FACTORS; JAW; BONE; MANAGEMENT; NECROSIS; CANCER; PAMIDRONATE; ASSOCIATION; INVOLVEMENT; ZOLEDRONATE;
D O I
10.1016/j.ijom.2010.11.006
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Bisphosphonates (BPs) are widely used as bone-stabilizers, but side effects of BP therapy include bisphosphonate-related osteonecrosis of the jaw (BRONJ), which is resistant to therapy. The aim of this study was to evaluate the outcome of maxillary BRONJ involving sinusitis maxillaris. 21 patients presenting with maxillary BRONJ, from 2005 to 2008, were included in the study. In 18 cases BP had been administered for carcinoma and in 3 cases for osteoporosis, with an average exposure time of 47.4 months. 12 patients spontaneously developed BRONJ. The 10 patients diagnosed with stage III BRONJ presented with concomitant sinusitis maxillaris. Despite treatment, there were six recurrences of BRONJ, four of them with additional sinusitis maxillaris. Whether BRONJ occurred spontaneously or after extraction there was no difference in the outcome. Patients with advanced maxillary BRONJ often suffer from sinusitis maxillaris, both of which are frequently resistant to therapy.
引用
收藏
页码:285 / 291
页数:7
相关论文
共 34 条
[1]   Bis-phossy jaws - High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw [J].
Abu-Id, Mario H. ;
Warnke, Patrick H. ;
Gottschalk, Joachim ;
Springer, Ingo ;
Wiltfang, Joerg ;
Acil, Yahya ;
Russ, Paul A. J. ;
Kreusch, Thomas .
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2008, 36 (02) :95-103
[2]  
Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724
[3]   Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases [J].
Bagan, JV ;
Murillo, J ;
Jimenez, Y ;
Poveda, R ;
Milian, MA ;
Sanchis, JM ;
Silvestre, FJ ;
Scully, C .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2005, 34 (02) :120-123
[4]   Suppurative intracranial complications of sinusitis in previously healthy children [J].
Bair-Merritt, MH ;
Shah, SS ;
Zaoutis, TE ;
Bell, LM ;
Feudtner, C .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (04) :384-386
[5]   Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors [J].
Bamias, A ;
Kastritis, E ;
Bamia, C ;
Moulopoulos, LA ;
Melakopoulos, L ;
Bozas, G ;
Koutsoukou, V ;
Gika, D ;
Anagnostopoulos, A ;
Papadimitriou, C ;
Terpos, E ;
Dimopoulos, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8580-8587
[6]   Microbiology of acute and chronic maxillary sinusitis associated with an odontogenic origin [J].
Brook, I .
LARYNGOSCOPE, 2005, 115 (05) :823-825
[7]   Osteonecrosis of the jaws associated with use of risedronate: Report of 2 new cases [J].
Brooks, John K. ;
Gilson, Allen J. ;
Sindler, Arnold J. ;
Ashman, Steven G. ;
Schwartz, Kevin G. ;
Nikitakis, Nikolaos G. .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2007, 103 (06) :780-786
[8]  
Dazert S, 2004, HNO, V52, P631, DOI 10.1007/s00106-003-0955-2
[9]  
Diel Ingo J, 2007, J Support Oncol, V5, P475
[10]   DIAGNOSIS AND TREATMENT OF INTRACRANIAL COMPLICATIONS OF PARANASAL SINUS INFECTIONS [J].
DOLAN, FW ;
CHOWDHURY, K .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1995, 53 (09) :1080-1087